发明名称 |
PHARMACEUTICAL COMPOSITION OF BUPROPION AND NALTREXONE |
摘要 |
A pharmaceutical composition of bupropion or salts thereof and naltrexone or salts thereof is provided. The composition comprises individual layers of bupropion or a pharmaceutically acceptable salt thereof and naltrexone or a pharmaceutically acceptable salt thereof in direct contact with each other and without being separated by any intermediate layer. A method of manufacturing the composition is also provided. |
申请公布号 |
US2016220562(A1) |
申请公布日期 |
2016.08.04 |
申请号 |
US201514611267 |
申请日期 |
2015.02.01 |
申请人 |
Gravis Pharmaceuticals |
发明人 |
Garegnani James;Kanniyappan Velayutham |
分类号 |
A61K31/485;A61K31/137;A61K9/20;A61K9/24 |
主分类号 |
A61K31/485 |
代理机构 |
|
代理人 |
|
主权项 |
1. A pharmaceutical composition comprising:
a. a first layer comprising bupropion or a pharmaceutically acceptable salt thereof; b. a second layer comprising naltrexone or a pharmaceutically acceptable salt thereof; and c. one or more pharmaceutically acceptable excipients;wherein the composition is devoid of an intermediate layer, and wherein following ingestion of the composition by a patient, the first layer of the bupropion or a pharmaceutically acceptable salt thereof dissolves as predicted by its individual dissolution profile and the second layer of the naltrexone or a pharmaceutically acceptable salt thereof dissolves as predicted by its individual dissolution profile. |
地址 |
Somerset NJ US |